FIELD: medicine, ophthalmology, chemical-pharmaceutical industry, pharmacy.
SUBSTANCE: invention relates to the development of the ophthalmic composition possessing with anti-histaminic activity. Anti-histaminic ophthalmic drops comprise zinc sulfate, diphenhydramine hydrochloride, naphazoline hydrochloride, sodium citrate, citric acid, benzalkonium chloride, methylene blue, sodium chloride, hydroxypropylmethylcellulose-4000, sodium hydroxide and distilled water taken in the definite weight ratio. Drops can be used in allergic conjunctivitis, blepharitis, eyelid nettle rash and insect stings. Invention provides expanding spectrum of pharmacological effect of agent in such diseases.
EFFECT: improved and valuable medicinal properties of drops.
2 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
EYE DROPS, WHICH HAVE ANTI-INFECTIOUS, ANTI-INFLAMMATORY AND ANTI-ALLERGIC ACTION | 2012 |
|
RU2493823C1 |
OPHTHALMIC COMPOSITION FOR TREATMENT OF CONJUNCTIVITES, BLEPARITIS AND MARGINAL CORNEAL ULCERS IN TOPICAL APPLICATION | 2016 |
|
RU2633055C1 |
THERAPEUTIC AGENT FOR TREATING ALLERGIC AND VIRAL OCULAR DISEASES IN FORM OF GEL OR GEL-LIKE DROPS | 2015 |
|
RU2595244C1 |
GEL EYE DROPS FOR CHRONIC AND ALLERGIC INFLAMMATORY DISEASES TREATMENT | 2016 |
|
RU2629590C1 |
EYE GEL DROPS FOR TREATING ACUTE AND CHRONIC INFLAMMATORY EYE DISEASES CAUSED BY VIRAL, BACTERIAL, ALLERGIC, METABOLIC OR TRAUMATIC FACTORS | 2018 |
|
RU2692087C1 |
EYE GEL DROPS FOR TREATMENT OF INFLAMMATORY, VIRUS, BACTERIAL, ALLERGIC, METABOLIC, TRAUMATIC DISEASES | 2017 |
|
RU2688687C1 |
ANTIBACTERIAL DRUG IN FORM OF OINTMENT FOR TREATING EYE DISEASES IN ANIMALS | 2015 |
|
RU2580631C1 |
LOW-DOSE BRIMONIDINE COMBINATIONS AND THEIR USE | 2018 |
|
RU2801221C2 |
GEL, POSSESSING ANTI- INFLAMMATORY AND ANTIALLERGIC EFFECT | 2008 |
|
RU2370265C1 |
ANTIBACTERIAL DRUG IN FORM OF DROPS FOR TREATING EYE DISEASES IN ANIMALS | 2015 |
|
RU2580630C1 |
Authors
Dates
2006-08-10—Published
2005-01-18—Filed